Administration of broadly neutralizing anti-HIV-1 antibodies at ART initiation maintains long-term CD8+ T cell immunity - Rosás-Umbert, Miriam; Gunst, Jesper D.; Pahus, Marie H.; Olesen, Rikke; Schleimann, Mariane; Denton, Paul W.; Ramos, Victor; Ward, Adam; Kinloch, Natalie N.; Copertino, Dennis C.; Escribà, Tuixent; Llano, Anuska; et al. (Nature communications, 2022)
Keywords: 13; 13/1; 13/21; 13/31; 631/250/255/1901; 692/308/575; Animals; Antibodies; Antibodies, Neutralizing; Antiretroviral therapy; Antiviral agents; Antiviral drugs; Broadly Neutralizing Antibodies; CD8 antigen; CD8-Positive T-Lymphocytes; Cell-mediated immunity; Gag protein; HIV; HIV Antibodies; HIV Infections; HIV-1; Human immunodeficiency virus; Humanities and Social Sciences; Humans; Immunity; Interferon; Interferon-gamma; Lymphocytes; Lymphocytes T; Macaca mulatta; multidisciplinary; Neutralizing; Primates; Science; Science (multidisciplinary); Simian Acquired Immunodeficiency Syndrome; Simian Immunodeficiency Virus; γ-Interferon